GlassScriptPhysician profile
Kevin Harris Thompson
NPI 1164587119
$56,268.05
in general payments reported to CMS, 2019-2025
46 companies · $1,431 in 2025
The $1,431 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $15K · 2021: $10K · 2022: $8,751 · 2023: $8,472 · 2024: $1,218 · 2025: $1,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,768 · Food and Beverage: $4,277 · Education: $76.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,767.50 |
| Food and Beverage | $4,277.06 |
| Education | $76.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $43,060.66 | 2019-2025 | Repatha, Repatha, Otezla |
| Angiodynamics, INC. | $4,800.00 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,786.48 | 2019-2025 | |
| Pfizer INC. | $1,152.10 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $887.24 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $479.83 | 2019-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $420.54 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $416.68 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $346.49 | 2021-2025 | Watchman Access System, Bodyguardian |
| Medtronic, INC. | $257.29 | 2021-2025 | Hawkone, Cobalt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $251.77 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $244.40 | 2019-2023 | Xarelto |
| Amarin Pharma, INC. | $198.04 | 2019-2021 | |
| Abiomed | $163.63 | 2019-2022 | |
| Esperion Therapeutics, INC. | $161.52 | 2021-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $132.22 | 2022-2024 | Optimizer, Optimizer |
| Alnylam Pharmaceuticals INC. | $130.01 | 2020-2025 | Amvuttra |
| Abbott Laboratories | $118.50 | 2021-2023 | Jot Dx |
| Regeneron Healthcare Solutions, INC. | $105.19 | 2019 | |
| Sanofi-Aventis U.S. LLC | $104.31 | 2019 | |
| Philips North America LLC | $99.99 | 2020-2022 | |
| Edwards Lifesciences Corporation | $96.82 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $96.77 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $93.47 | 2019-2025 | Uptravi, Opsynvi |
| Lundbeck LLC | $63.84 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.24 | 2021-2025 | |
| Chiesi USA, INC. | $48.12 | 2020-2025 | Juxtapid |
| Celgene Corporation | $48.04 | 2024 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals, LTD. | $42.18 | 2021-2023 | Arcalyst |
| Novo Nordisk INC | $38.21 | 2022-2025 | Wegovy |
| Genzyme Corporation | $38.02 | 2019-2021 | |
| Scpharmaceuticals INC. | $35.97 | 2023-2025 | |
| Inspire Medical Systems, INC. | $33.36 | 2024-2025 | Inspire |
| Teleflex LLC | $29.01 | 2023 | Vascband, Guideliner |
| Silk Road Medical, INC. | $28.22 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Cmp Pharma, INC. | $28.22 | 2021 | |
| Coala Life INC | $23.33 | 2021 | |
| Stryker Corporation | $23.27 | 2025 | Flowtriever |
| Lexicon Pharmaceuticals, INC. | $22.99 | 2023 | Inpefa |
| Heartflow, INC. | $19.83 | 2021 | |
| Terumo Medical Corporation | $17.97 | 2019 | |
| Irhythm Technologies, INC. | $15.41 | 2020 | |
| Tactile Systems Technology INC | $13.12 | 2021 | |
| Cardiovascular Systems INC. | $12.81 | 2022 | |
| Gilead Sciences, INC. | $12.10 | 2019 | |
| Amryt Pharma Holdings LTD | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.